Ref: Li,D. and Gao,Z. unpublished

REBASE ref # 27314

Sequence length:GenBank #:
Chromosome: 5,511,250 bp CP026145
plasmid pF132_1: 113,265 bp CP026146
plasmid pF132_2: 71,854 bp CP026147

REBASE acronym: KpnF132

Org_num: 33210

 

All begin C2M08_

Type I
ORF Gene Most similar Specificity Name
 
plasmid pF132_1
 
28330 DUF262 domain-containing protein
28335 M M.KpnsF5ORF29200P (100% identity) M.KpnF132ORF28335P
28340 S S.KpnsF5ORF29200P (100% identity) S.KpnF132ORF28335P
28345 R KpnsF5ORF29200P (100% identity) KpnF132ORF28335P
28350 DNA modification methylase
Type II
ORF Gene Most similar Specificity Name
 
Chromosome
 
1890 cell division protein DamX
1895 M M.KspC31DamP (100% identity) GATC M.KpnF132DamP
1900 ribulose-phosphate 3-epimerase
 
6335 75 aa hypothetical protein
6340 M M.Ksp1927ORF4530P (100% identity) M.KpnF132ORF6340P
6345 endonuclease
 
7105 80 aa hypothetical protein
7110 M M.KpnvKP8ORFDP (100% identity) M.KpnF132ORF7110P
7115 220 aa hypothetical protein
 
9780 phosphohydrolase
9785 M M.Ksp1927ORF7915P (100% identity) CCWGG M.KpnF132ORF9785P
9790 V V.Ksp2N3ORFEP (75% identity) V.KpnF132ORF9785P
9795 drug/metabolite exporter YedA
 
16035 regulator
16040 M M.Ksp1927ORF14405P (100% identity) M.KpnF132ORF16040P
16045 104 aa hypothetical protein
 
25085 DNA topoisomerase III
25090 M M.Ssp405ORF8290P (100% identity) M.KpnF132ORF25090P
25095 185 aa hypothetical protein
 
plasmid pF132_1
 
28385 75 aa hypothetical protein
28390 M M.KpnsF5ORF29255P (100% identity) M.KpnF132ORF28390P
28395 277 aa hypothetical protein
 
28490 XRE family transcriptional regulator
28495 R KpnsF5ORF29350P (100% identity) KpnF132ORF28500P
28500 M M.KpnsF5ORF29350P (100% identity) M.KpnF132ORF28500P
28505 214 aa hypothetical protein
 
plasmid pF132_2
 
28925 DNA breaking-rejoining protein
28930 M M.YpeZORF72P (100% identity) M.KpnF132ORF28930P
28935 73 aa hypothetical protein
Tech Support Feedback NEB Overview Site Map Trademarks Legal and Disclaimers Privacy Cookie Policy Terms of Use
© Copyright 2023 New England Biolabs. All Rights Reserved.